Hispanic/Latino Ethnicity is an Independent Predictor of Worse Survival for Gastric Cancer in a Multicenter Safety-Net Patient Population

Inflammatory Bowel Disease

Risk of incident cancer in patients with Inflammatory Bowel Disease with prior breast cancer: a multicenter cohort study

Clin Gastroenterol Hepatol

Cosquer GL, Kirchgesner J, Joseph CGS, Seksik P, Amiot A, Laharie D, Nachury M, Rouillon C, Abitbol V, Nuzzo A, Nancey S, Fumery M, Biron A, Richard N, Altwegg R, Moussata D, Caron B, Vidon M, Reenaers C, Uzzan M, Jean-Marie R, Serrero M, Simon M, Benezech A, Goutorbe F, Anne-Laure P, Caillo L, Vaysse C, Poullenot F, getaid

doi: 10.1016/j.cgh.2024.09.034

Gastrointestinal Cancer

Disease-free survival as surrogate for overall survival in esophageal cancer: An individual patient data meta-analysis of neoadjuvant chemotherapy and chemoradiotherapy

Eur J Cancer

Cabrit N, Cheugoua-Zanetsie M, Tierney J, Thirion P, Nankivell M, Winter K, Yang H, Wijnhoven B, Vernerey D, Smithers BM, Piessen G, Nilsson M, Boonstra J, Ychou M, Law S, Cunningham D, Vathaire F, Stahl M, Urba S, Valmasoni M, Williaume D, Thomas J, Lordick F, Tepper J, Gebski V, Burmeister B, Paoletti X, Sandick JV, Fu J, Pignon JP, Ducreux M, Faron M, Michiels S, MANATEC-02 collaborative group

doi: 10.1016/j.ejca.2025.115292

Gastrointestinal Cancer

A multicenter, prospective, phase II trial of second-line aflibercept plus FOLFIRI in patients with metastatic colorectal cancer refractory to an anti-EGFR antibody: HGCSG1801

Int J Cancer

Nakatsumi H, Komatsu Y, Harada K, Kawamoto Y, Yuki S, Sawada K, Ishiguro A, Sogabe S, Ando T, Sasaki Y, Yoshikawa A, Nakamura M, Dazai M, Tateyama M, Muto O, Kotaka M, Sagawa T, Muranaka T, Hatanaka K, Takagi R, Sakata Y

doi: 10.1002/ijc.35116

Gastrointestinal Cancer

Staging accuracy in patients with clinical T2N0 gastric cancer: Implications for treatment sequencing

Surgery

Baril JA, Ruedinger BM, Nguyen TK, Bilimoria KY, Ceppa EP, Maatman TK, Roch AM, Schmidt CM, Turk A, Yang AD, House MG, Ellis RJ

doi: 10.1016/j.surg.2024.07.055

Gastrointestinal Cancer

Oxaliplatin Added to Fluoropyrimidine/Bevacizumab as Initial Therapy for Unresectable Metastatic Colorectal Cancer in Older Patients: A Multicenter, Randomized, Open-Label Phase III Trial (JCOG1018)

J Clin Oncol

Takashima A, Hamaguchi T, Mizusawa J, Nagashima F, Ando M, Ojima H, Denda T, Watanabe J, Shinozaki K, Baba H, Asayama M, Hasegawa S, Masuishi T, Nakata K, Tsukamoto S, Katayama H, Nakamura K, Fukuda H, Kanemitsu Y, Shimada Y, Colorectal Cancer Study Group in Japan Clinical Oncology Group (JCOG)

doi: 10.1200/JCO.23.02722

Gastrointestinal CancerHepatology

Older age but not comorbidity is associated with worse survival in patients with hepatocellular carcinoma

Clin Gastroenterol Hepatol

Kanneganti M, Al-Hasan M, Bourque S, Deodhar S, Yang JD, Huang DQ, Kulkarni AV, Gopal P, Parikh ND, Kanwal F, Patel MS, Singal AG

doi: 10.1016/j.cgh.2024.10.015

Gastrointestinal Cancer

Systemic Treatment Strategies and Outcomes of Patients With Synchronous Peritoneal Metastases of Gastric Origin: A Nationwide Population-Based Study

J Natl Compr Canc Netw

Guchelaar NAD, Noordman BJ, Welten MW, van Santen MT, de Neijs MJ, Koolen SLW, Verhoeven RHA, Oomen-de Hoop E, van der Sluis PC, Lagarde SM, van Laarhoven HWM, de Hingh IHJT, Creemers GJ, Mostert B, Wijnhoven BPL, Mathijssen RHJ

doi: 10.6004/jnccn.2024.7013

Inflammatory Bowel Disease

Independent Predictors of 90-Day Readmission in Patients with Inflammatory Bowel Disease: A Nationwide Retrospective Study

J Crohns Colitis

Kunkle B, Singh H, Abraham D, Asamoah N, Barrow J, Mattar M

doi: 10.1093/ecco-jcc/jjaf034

Inflammatory Bowel Disease

Predictors for chronic opioid use in patients with inflammatory bowel disease - a population based cohort study

Am J Gastroenterol

Nørgård BM, Thorarinsson CT, Nielsen J, Dalal RS, Andersen ML, Lund K, Friedman S, Knudsen T, Kjeldsen J

doi: 10.14309/ajg.0000000000003353

Related content

Risk of incident cancer in patients with Inflammatory Bowel Disease with prior breast cancer: a multicenter cohort study

Disease-free survival as surrogate for overall survival in esophageal cancer: An individual patient data meta-analysis of neoadjuvant chemotherapy and chemoradiotherapy

A multicenter, prospective, phase II trial of second-line aflibercept plus FOLFIRI in patients with metastatic colorectal cancer refractory to an anti-EGFR antibody: HGCSG1801

Staging accuracy in patients with clinical T2N0 gastric cancer: Implications for treatment sequencing

Oxaliplatin Added to Fluoropyrimidine/Bevacizumab as Initial Therapy for Unresectable Metastatic Colorectal Cancer in Older Patients: A Multicenter, Randomized, Open-Label Phase III Trial (JCOG1018)

Older age but not comorbidity is associated with worse survival in patients with hepatocellular carcinoma

Systemic Treatment Strategies and Outcomes of Patients With Synchronous Peritoneal Metastases of Gastric Origin: A Nationwide Population-Based Study

Independent Predictors of 90-Day Readmission in Patients with Inflammatory Bowel Disease: A Nationwide Retrospective Study

Predictors for chronic opioid use in patients with inflammatory bowel disease - a population based cohort study